Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Bolon

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
Toxicologic Pathology|May 3, 2012
Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult miceMary Beth Genter, Nicholas C Newman, Howard G Shertzer, et al.
Toxicologic Pathology|December 27, 2024
Pathology Findings and In-Life Correlates in the Nonclinical Development of Adeno-Associated Virus (AAV)-Based Retinal Gene TherapiesHelen S Booler, Typhaine Lejeune, Oliver Turner, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 22, 2022
Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartameSusan A Elmore, Jerold E Rehg, Trenton R Schoeb, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 1, 2024
Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in a lifetime rodent carcinogenicity bioassay of sucraloseSusan A Elmore, Jerold E Rehg, Trenton R Schoeb, et al.
Journal of Biomedicine & Biotechnology|January 22, 2011
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacyBrad Bolon, Marina Stolina, Caroline King, et al.
Toxicologic Pathology|December 26, 2015
Scientific and Regulatory Policy Committee: Recommended ("Best") Practices for Determining, Communicating, and Using Adverse Effect Data from Nonclinical StudiesRoy Kerlin, Brad Bolon, John Burkhardt, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 28, 2023
Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?Susan A Elmore, Jerold E Rehg, Trenton R Schoeb, et al.
International Journal of Paleopathology|February 12, 2019
New world origin of canine distemper: Interdisciplinary insightsElizabeth W Uhl, Charles Kelderhouse, Jane Buikstra, et al.
Bone|March 31, 2004
Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized micePaul J Kostenuik, Brad Bolon, Sean Morony, et al.
Toxicologic Pathology|December 9, 2025
Toxicologic Pathology Forum*: Summary of the 2024 Society of Toxicologic Pathology Town Hall and 2025 STP Member Survey on Determining and Communicating AdversityKathleen A Funk, Lyn M Wancket, Brad Bolon, et al.
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Toxicologic Pathology|May 3, 2012
Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult miceMary Beth Genter, Nicholas C Newman, Howard G Shertzer, et al.
Toxicologic Pathology|December 27, 2024
Pathology Findings and In-Life Correlates in the Nonclinical Development of Adeno-Associated Virus (AAV)-Based Retinal Gene TherapiesHelen S Booler, Typhaine Lejeune, Oliver Turner, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 22, 2022
Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartameSusan A Elmore, Jerold E Rehg, Trenton R Schoeb, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 1, 2024
Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in a lifetime rodent carcinogenicity bioassay of sucraloseSusan A Elmore, Jerold E Rehg, Trenton R Schoeb, et al.
Journal of Biomedicine & Biotechnology|January 22, 2011
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacyBrad Bolon, Marina Stolina, Caroline King, et al.
Toxicologic Pathology|December 26, 2015
Scientific and Regulatory Policy Committee: Recommended ("Best") Practices for Determining, Communicating, and Using Adverse Effect Data from Nonclinical StudiesRoy Kerlin, Brad Bolon, John Burkhardt, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 28, 2023
Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?Susan A Elmore, Jerold E Rehg, Trenton R Schoeb, et al.
International Journal of Paleopathology|February 12, 2019
New world origin of canine distemper: Interdisciplinary insightsElizabeth W Uhl, Charles Kelderhouse, Jane Buikstra, et al.
Bone|March 31, 2004
Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized micePaul J Kostenuik, Brad Bolon, Sean Morony, et al.
Toxicologic Pathology|December 9, 2025
Toxicologic Pathology Forum*: Summary of the 2024 Society of Toxicologic Pathology Town Hall and 2025 STP Member Survey on Determining and Communicating AdversityKathleen A Funk, Lyn M Wancket, Brad Bolon, et al.
Pageof 20